These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 15817508)

  • 1. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia.
    Maynard SE; Venkatesha S; Thadhani R; Karumanchi SA
    Pediatr Res; 2005 May; 57(5 Pt 2):1R-7R. PubMed ID: 15817508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A; Rana S; Karumanchi SA
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
    Silasi M; Cohen B; Karumanchi SA; Rana S
    Obstet Gynecol Clin North Am; 2010 Jun; 37(2):239-53. PubMed ID: 20685551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of preeclampsia.
    Matsubara K; Nagamatsu T; Fujii T; Kozuma S; Taketani Y
    J Reprod Immunol; 2005 Dec; 68(1-2):27-37. PubMed ID: 16229897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology and clinical manifestations in pre-eclampsia].
    Haram K; Bjørge L; Guttu K
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1426-31. PubMed ID: 10851940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in gestational vascular complications.
    Yagel S
    Thromb Res; 2011 Feb; 127 Suppl 3():S64-6. PubMed ID: 21262445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity.
    Taché V; LaCoursiere DY; Saleemuddin A; Parast MM
    Hum Pathol; 2011 Sep; 42(9):1283-8. PubMed ID: 21334711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
    Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
    Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
    Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
    Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
    Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preeclampsia and angiogenic imbalance.
    Maynard S; Epstein FH; Karumanchi SA
    Annu Rev Med; 2008; 59():61-78. PubMed ID: 17937587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic and antiangiogenic factors in preeclampsia.
    Helmo FR; Lopes AMM; Carneiro ACDM; Campos CG; Silva PB; Dos Reis Monteiro MLG; Rocha LP; Dos Reis MA; Etchebehere RM; Machado JR; Corrêa RRM
    Pathol Res Pract; 2018 Jan; 214(1):7-14. PubMed ID: 29174227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
    Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects in the pathophysiology of preeclampsia.
    Davison JM; Homuth V; Jeyabalan A; Conrad KP; Karumanchi SA; Quaggin S; Dechend R; Luft FC
    J Am Soc Nephrol; 2004 Sep; 15(9):2440-8. PubMed ID: 15339993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.